Literature DB >> 16907904

Statins for non-alcoholic fatty liver disease: a new indication?

E N Liberopoulos, V G Athyros, M S Elisaf, D P Mikhailidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16907904     DOI： 10.1111/j.1365-2036.2006.03021.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  5 in total

Review 1.  Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Authors:  Juan P Arab; Roberto Candia; Rodrigo Zapata; Cristián Muñoz; Juan P Arancibia; Jaime Poniachik; Alejandro Soza; Francisco Fuster; Javier Brahm; Edgar Sanhueza; Jorge Contreras; M Carolina Cuellar; Marco Arrese; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 2.  Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider.

Authors:  Elisa Biondi
Journal:  Neurol Sci       Date:  2010-10-19       Impact factor: 3.307

3.  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.

Authors:  Vassilios G Athyros; Olga Giouleme; Emmanouel S Ganotakis; Moses Elisaf; Konstantinos Tziomalos; Themistoklis Vassiliadis; Evangelos N Liberopoulos; Eleni Theocharidou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

4.  Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.

Authors:  Kei Nakajima
Journal:  Int J Hepatol       Date:  2012-12-09

5.  Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study.

Authors:  Vasilios G Athyros; Niki Katsiki; Konstantinos Tziomalos; Thomas D Gossios; Eleni Theocharidou; Eygenia Gkaliagkousi; Panagiotis Anagnostis; Efstathios D Pagourelias; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2013-05-28       Impact factor: 3.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.